Alle verbonden artikelen

Predictors of physicians' satisfaction with their management of uncertainty during a decision-making encounter with a simulated advanced stage cancer patient.

Auteurs : Libert Y, Canivet D, Ménard C, Van Achte L, Farvacques C, Merckaert I, Liénard A, Klastersky J, Reynaert C, Slachmuylder JL, Durieux JF, Delvaux N, Razavi D
Jaar : 2016
Journal : Patient Educ Couns
Volume : 99(7)
Pagina's : 1121-9

Portraying breast cancers with long noncoding RNAs.

Auteurs : Van Grembergen O, Bizet M, de Bony EJ, Calonne E, Putmans P, Brohée S, Olsen C, Guo M, Bontempi G, Sotiriou C, Defrance M, Fuks F
Jaar : 2016
Journal : Sci Adv
Volume : 2
Pagina's : e1600220

Cancer drugs, survival and ethics: a critical look from the inside.

Auteurs : Piccart-Gebhart M, Pondé N
Jaar : 2016
Journal : ESMO Open
Volume : 1
Pagina's : e000149

Rare side-effects of checkpoint inhibitors.

Auteurs : Kourie HR, Awada G, Awada A
Jaar : 2016
Journal : Curr Opin Oncol
Volume : 28
Pagina's : 295-305

I-SPY 2: optimising cancer drug development in the 21st century.

Auteurs : Bartsch R, de Azambuja E
Jaar : 2016
Journal : ESMO Open
Volume : 1
Pagina's : e000113

Genomic Characterization of Primary Invasive Lobular Breast Cancer.

Auteurs : Desmedt C, Zoppoli G, Gundem G, Pruneri G, Larsimont D, Fornili M, Fumagalli D, Brown D, Rothé F, Vincent D, Kheddoumi N, Rouas G, Majjaj S, Brohée S, Van Loo P, Maisonneuve P, Salgado R, Van Brussel T, Lambrechts D, Bose R, Metzger O, Galant C, Bertucci F, Piccart-Gebhart M, Viale G, Biganzoli E, Campbell PJ, Sotiriou C
Jaar : 2016
Journal : J Clin Oncol
Volume : 34(16)
Pagina's : 1872-81

Pathway level alterations rather than mutations in single genes predict response to HER2 targeted therapies in the neo-ALTTO trial.

Auteurs : Shi W, Jiang T, Nuciforo P, Hatzis C, Holmes E, Harbeck N, Sotiriou C, Peña L, Loi S, Rosa DD, Chia S, Wardley A, Ueno T, Rossari J, Eidtmann H, Armour A, Piccart-Gebhart M, Rimm DL, Baselga J, Pusztai L
Jaar : 2016
Journal : Ann Oncol
Volume : 28(1)
Pagina's : 128-35

The European Cancer Patient's Bill of Rights, update and implementation 2016.

Auteurs : Højgaard L, Löwenberg B, Selby P, Lawler M, Banks I, Law K, Albreht T, Armand JP, Barbacid M, Barzach M, Bergh J, Cameron D, Conte P, de Braud F, de Gramont A, de Lorenzo F, Diehl V, Diler S, Erdem S, Geissler J, Gore-Booth J, Henning G, Horgan D, Jassem J, Johnson P, Kaasa S, Kapitein P, Karjalainen S, Kelly J, Kienesberger A, La Vecchia C, Lacombe D, Lindahl T, Luzzatto L, Malby R, Mastris K, Meunier F, Murphy M, Naredi P, Nurse P, Oliver K, Pearce J, Pelouchov J, Piccart-Gebhart M, Pinedo B, Spurrier-Bernard G, Sullivan R, Tabernero J, van de Velde C, van Herk B, Vedsted P, Waldmann A, Weller D, Wilking N, Wilson R, Yared W, Zielinski C, Zur Hausen H, Le Chevalier T, Johnston P
Jaar : 2016
Journal : ESMO Open
Volume : 1
Pagina's : e000127

Validation of the EORTC QLQ-INFO 25 questionnaire in Lebanese cancer patients: Is ignorance a Bliss?

Auteurs : Tabchi S, El Rassy E, Khazaka A, El Karak F, Kourie HR, Chebib R, Assi T, Ghor M, Naamani L, Richa S, Ghosn M, Kattan J
Jaar : 2016
Journal : Qual Life Res
Volume : 25
Pagina's : 1597-604

Improved Survival of Calreticulin-Mutated Patients Compared With Janus Kinase 2 in Primary Myelofibrosis: A Meta-Analysis.

Auteurs : Kourie HR, Ameye L, Paesmans M, Bron D
Jaar : 2016
Journal : Clin Lymphoma Myeloma Leuk
Volume : 16(5)
Pagina's : 264-8

Endocrine treatment in breast cancer: Cure, resistance and beyond.

Auteurs : Tryfonidis K, Zardavas D, Katzenellenbogen BS, Piccart-Gebhart M
Jaar : 2016
Journal : Cancer Treat Rev
Volume : 50
Pagina's : 68-81

Pictilisib for oestrogen receptor-positive, aromatase inhibitor-resistant, advanced or metastatic breast cancer (FERGI): a randomised, double-blind, placebo-controlled, phase 2 trial.

Auteurs : Krop IE, Mayer IA, Ganju V, Dickler M, Johnston S, Morales S, Yardley DA, Melichar B, Forero-Torres A, Lee SC, de Boer R, Petrakova K, Vallentin S, Perez EA, Piccart-Gebhart M, Ellis M, Winer E, Gendreau S, Derynck M, Lackner M, Levy G, Qiu J, He J, Schmid P
Jaar : 2016
Journal : Lancet Oncol
Volume : 17
Pagina's : 811-21

Histological transformation of ALK rearranged adenocarcinoma into small cell lung cancer: A new mechanism of resistance to ALK inhibitors.

Auteurs : Levacq D, DHaene N, de Wind R, Remmelink M, Berghmans T
Jaar : 2016
Journal : Lung Cancer
Volume : 102
Pagina's : 38-41

The current use and attitudes towards tumor genome sequencing in breast cancer.

Auteurs : Gingras I, Sonnenblick A, de Azambuja E, Paesmans M, Delaloge S, Aftimos P, Piccart-Gebhart M, Sotiriou C, Ignatiadis M, Azim HA Jr
Jaar : 2016
Journal : Sci Rep
Volume : 6
Pagina's : 22517

Reply to the letter to the editor 'Utilisation of the ESMO-MCBS in practice of HTA' by Wild et al.

Auteurs : Cherny NI, Sullivan R, Dafni U, Bogaerts J, Kerst JM, Zielinski C, Piccart-Gebhart M, de Vries EG
Jaar : 2016
Journal : Ann Oncol
Volume : 27(11)
Pagina's : 2136-7

Lapatinib-Related Rash and Breast Cancer Outcome in the ALTTO Phase III Randomized Trial.

Auteurs : Sonnenblick A, de Azambuja E, Agbor-Tarh D, Bradbury I, Campbell C, Huang Y, Dueck AC, Pritchard KI, Wolff AC, Jackisch C, Lang I, Untch M, Smith I, Boyle F, Xu B, Gomez H, Perez EA, Piccart-Gebhart M, Azim HA Jr
Jaar : 2016
Journal : J Natl Cancer Inst
Volume : 108

Faut-il réévaluer les indications pour l’utilisation des facteurs stimulant la granulopoïèse en fonction des comorbidités présentées par les patients?

Auteurs : Klastersky J, Paesmans M
Jaar : 2016
Journal : Onco-Hémato
Volume : -
Pagina's : 4 pages

Side-effects of checkpoint inhibitor-based combination therapy.

Auteurs : Kourie HR, Klastersky J
Jaar : 2016
Journal : Curr Opin Oncol
Volume : 28
Pagina's : 306.13

Feasibility Study of EndoTAG-1, a Tumor Endothelial Targeting Agent, in Combination with Paclitaxel followed by FEC as Induction Therapy in HER2-Negative Breast Cancer.

Auteurs : Ignatiadis M, Zardavas D, Lemort M, Wilke C, Vanderbeeken MC, Dhondt V, de Azambuja E, Gombos A, Lebrun F, Dal Lago L, Bustin F, Maetens M, Ameye L, Veys I, Michiels S, Paesmans M, Larsimont D, Sotiriou C, Nogaret JM, Piccart-Gebhart M, Awada A
Jaar : 2016
Journal : PLoS One
Volume : 11(7)
Pagina's : e0154009

The emerging problem of bacterial resistance in cancer patients; proceedings of a workshop held by MASCC Neutropenia, Infection and Myelosuppression" Study Group during the MASCC annual meeting held in Berlin on 27-29 June 2013."

Auteurs : Rapoport B, Klastersky J, Raftopoulos H, Freifeld A, Aoun M, Zinner SH, Rolston KV
Jaar : 2016
Journal : Support Care Cancer
Volume : 24(7)
Pagina's : 2819-26